Natera Stock Surges After Coming Out Ahead In Ravgen Patent Battle
Natera (NTRA) stock surged Wednesday after a jury said the DNA-testing company must pay competitor Ravgen $57 million in a patent lawsuit — significantly below the $410 million its rival originally requested.
X
Importantly,…